Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Angion Biomedica presents aldosterone synthase inhibitors

July 22, 2016

Scientists discover novel ROMK inhibitor SHR-1977 for treating hypertension

July 20, 2016

ADCY9 gene polymorphisms affect dalcetrapib effects on cardiovascular outcomes

July 19, 2016

WARS2 gene linked to angiogenesis within and outside the heart

July 12, 2016

AOP Orphan Pharmaceuticals' Rapibloc approved in Europe

July 12, 2016

FDA issues complete response letter for Aggrastat in new STEMI indication

July 8, 2016

Actelion initiates phase III TOMORROW study to evaluate macitentan in children with PAH

July 7, 2016

FDA approves Abbott's Absorb absorbable stent for coronary heart disease

July 7, 2016

Quantum Genomics initiates phase IIa trial of QGC-101 for heart failure

July 6, 2016

Maruho's Hemangiol receives Japanese approval for treatment of infantile hemangioma

July 5, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...